Standard BioTools Inc.
LAB
$1.06
-$0.0143-1.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -72.29% | -28.29% | -168.30% | -90.92% | 5.13% |
| Total Depreciation and Amortization | 1.20% | -33.56% | 432.81% | 148.03% | 376.92% |
| Total Amortization of Deferred Charges | -- | 55.16% | -119.46% | 9.14% | -- |
| Total Other Non-Cash Items | 83.89% | 21.05% | 49.31% | -400.37% | 80.49% |
| Change in Net Operating Assets | 412.35% | -1,574.34% | -714.78% | -6,297.80% | 43.99% |
| Cash from Operations | 0.01% | -144.21% | -318.59% | -636.31% | 26.69% |
| Capital Expenditure | -4,235.90% | -149.17% | -131.15% | 22.67% | 89.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 333.86% | 41.60% | 27.41% | -12.09% | -131.80% |
| Cash from Investing | 296.13% | 38.14% | 25.25% | 637.07% | -132.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4,300.00% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 24.70% | -15.00% | 330.98% | -- | 30.34% |
| Repurchase of Common Stock | 74.14% | 82.97% | -1,135.10% | -332.68% | 70.66% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5,335.69% | 99.83% | -1,260.89% | -671.42% | -271.48% |
| Foreign Exchange rate Adjustments | -216.09% | -177.55% | -23.61% | -191.30% | -26.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.27% | 5.57% | -160.21% | 633.94% | -232.41% |
